Skip to content
All Podcasts – Lifestyle
Author:
Edison Oncology Holding Corp.
Edison Oncology Appoints Michael Faber to Board of Directors and Announces Five Poster Presentations at Two Peer-Reviewed Oncology Meetings in November 2026
October 20, 2026
Edison Oncology and Senz Oncology Complete Enrollment in Phase 1-2a Trial of EO1001, Advancing Development in ErbB-Driven Cancers
July 30, 2026
Edison Oncology Presents EO1001 Trials-in-Progress Poster at ASCO 2026, Highlighting Differentiated Activity in EGFR Extracellular Domain Mutant Cancers with No Approved Targeted Therapy
June 1, 2026